Earlier studies suggested that non-diabetic patients with sustained hyperglycemia benefit greatly from tight glycemic control (target level of 80–110 mg/dL) by using insulin therapy, which can reduce mortality significantly among medical and surgical patients [26]. Here, INS is linked to Hyperglycemia.